• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

癌症与食管动力障碍疾病关联的机制。

The Mechanisms for the Association of Cancer and Esophageal Dysmotility Disorders.

机构信息

Hospital Israelita Albert Einstein, Sao Paulo 05652-900, Brazil.

Department of Gastroenterology, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo 05403-000, Brazil.

出版信息

Med Sci (Basel). 2021 May 21;9(2):32. doi: 10.3390/medsci9020032.

DOI:10.3390/medsci9020032
PMID:34064058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8163009/
Abstract

BACKGROUND

Achalasia and other esophageal dysmotility disorders mimicking achalasia can be associated with cancer. This study aimed to review the main mechanisms for which cancer may develop in esophageal dysmotility disorder patients.

METHODS

A narrative review was performed.

RESULTS

The mechanism for developing squamous cell carcinoma and adenocarcinoma are discussed. Besides, achalasia-like syndromes related to familial KIT-gene mutation and pseudoachalasia are discussed.

CONCLUSIONS

Knowing the main mechanism for which achalasia can be related to cancer is essential for clinicians to conduct the proper investigation, surveillance, and treatment.

摘要

背景

贲门失弛缓症和其他类似贲门失弛缓症的食管动力障碍性疾病可能与癌症有关。本研究旨在综述癌症可能在食管动力障碍性疾病患者中发展的主要机制。

方法

进行了叙述性综述。

结果

讨论了发展鳞状细胞癌和腺癌的机制。此外，还讨论了与家族性 KIT 基因突变相关的贲门失弛缓样综合征和假性贲门失弛缓症。

结论

了解贲门失弛缓症与癌症相关的主要机制对于临床医生进行适当的检查、监测和治疗至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f8/8163009/529956868d7d/medsci-09-00032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f8/8163009/529956868d7d/medsci-09-00032-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f8/8163009/529956868d7d/medsci-09-00032-g001.jpg

相似文献

1
The Mechanisms for the Association of Cancer and Esophageal Dysmotility Disorders.癌症与食管动力障碍疾病关联的机制。
Med Sci (Basel). 2021 May 21;9(2):32. doi: 10.3390/medsci9020032.
2
Infiltrating carcinoma simulating achalasia.浸润性癌模拟贲门失弛缓症。
Gastrointest Radiol. 1976 Nov 30;1(3):245-8. doi: 10.1007/BF02256373.
3
Esophageal achalasia: a risk factor for carcinoma. A systematic review and meta-analysis.食管贲门失弛缓症：一种癌症风险因素。系统评价与荟萃分析。
Dis Esophagus. 2017 Oct 1;30(10):1-8. doi: 10.1093/dote/dox072.
4
The pathogenesis of pseudoachalasia: a clinicopathologic study of 13 cases of a rare entity.假性贲门失弛缓症的发病机制：13例罕见病例的临床病理研究
Am J Surg Pathol. 2002 Jun;26(6):784-8. doi: 10.1097/00000478-200206000-00013.
5
Risk of Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus in Patients With Achalasia: A Long-Term Prospective Cohort Study in Italy.意大利一项长期前瞻性队列研究：贲门失弛缓症患者罹患食管鳞癌和腺癌的风险。
Am J Gastroenterol. 2021 Feb 1;116(2):289-295. doi: 10.14309/ajg.0000000000000955.
6
Endoscopic Surveillance in Idiopathic Achalasia.特发性贲门失弛缓症的内镜监测
Cureus. 2021 Aug 25;13(8):e17436. doi: 10.7759/cureus.17436. eCollection 2021 Aug.
7
Esophageal Dysbiosis in Achalasia and Cancer Development: A Critical Review.贲门失弛缓症和癌症发展中的食管菌群失调：批判性综述。
Genes (Basel). 2023 Jul 26;14(8):1521. doi: 10.3390/genes14081521.
8
Pseudoachalasia as a result of metastatic cervical cancer.转移性宫颈癌导致的假性贲门失弛缓症。
JSLS. 2001 Jan-Mar;5(1):57-62.
9
Primary esophageal motility disorders.原发性食管动力障碍
Mayo Clin Proc. 2001 Feb;76(2):195-200. doi: 10.1016/S0025-6196(11)63127-3.
10
Pseudo-achalasic behaviour of a middle thoracic esophageal squamous cell carcinoma.中段胸段食管鳞状细胞癌的假性失弛缓行为
Chirurgia (Bucur). 2008 Sep-Oct;103(5):595-600.

引用本文的文献

1
Late Onset of Pseudoachalasia in Anti-Hu-Associated Syndrome.抗Hu相关综合征中假性贲门失弛缓症的迟发表现。
Case Rep Gastrointest Med. 2025 Jun 16;2025:6627099. doi: 10.1155/crgm/6627099. eCollection 2025.
2
Delayed Presentation of Malignancy-Associated Pseudoachalasia of the Gastric Cardia.贲门恶性肿瘤相关性假性贲门失弛缓症的延迟表现
Cureus. 2024 Feb 11;16(2):e54040. doi: 10.7759/cureus.54040. eCollection 2024 Feb.
3
Esophageal Dysbiosis in Achalasia and Cancer Development: A Critical Review.贲门失弛缓症和癌症发展中的食管菌群失调：批判性综述。

本文引用的文献

1
Achalasia and esophageal cancer: a large database analysis in Japan.贲门失弛缓症与食管癌：日本大型数据库分析。
J Gastroenterol. 2021 Apr;56(4):360-370. doi: 10.1007/s00535-021-01763-6. Epub 2021 Feb 4.
2
Risk assessment of nitrate and nitrite in feed.饲料中硝酸盐和亚硝酸盐的风险评估
EFSA J. 2020 Nov 4;18(11):e06290. doi: 10.2903/j.efsa.2020.6290. eCollection 2020 Nov.
3
Achalasia: A mechanical and sensitivity disorder.贲门失弛缓症：一种机械性和敏感性障碍。
Genes (Basel). 2023 Jul 26;14(8):1521. doi: 10.3390/genes14081521.
4
Pathogenesis, clinical manifestations, diagnosis, and treatment progress of achalasia of cardia.贲门失弛缓症的发病机制、临床表现、诊断及治疗进展
World J Clin Cases. 2023 Mar 16;11(8):1741-1752. doi: 10.12998/wjcc.v11.i8.1741.
5
Evaluating the Non-conventional Achalasia Treatment Modalities.评估贲门失弛缓症的非常规治疗方式。
Front Med (Lausanne). 2022 Jun 24;9:941464. doi: 10.3389/fmed.2022.941464. eCollection 2022.
6
Microbial Dysbiosis in Achalasia: Insights on How to Prevent Cancer.贲门失弛缓症中的微生物群落失调：关于如何预防癌症的见解
J Neurogastroenterol Motil. 2022 Jul 30;28(3):506-507. doi: 10.5056/jnm22076.
7
Hidden in Plain Sight: Esophageal Dysmotility in Patients With Systemic Lupus Erythematosus.隐匿于众目睽睽之下：系统性红斑狼疮患者的食管动力障碍
Cureus. 2022 Mar 16;14(3):e23208. doi: 10.7759/cureus.23208. eCollection 2022 Mar.
8
Endoscopic Surveillance in Idiopathic Achalasia.特发性贲门失弛缓症的内镜监测
Cureus. 2021 Aug 25;13(8):e17436. doi: 10.7759/cureus.17436. eCollection 2021 Aug.
United European Gastroenterol J. 2020 Nov;8(9):1126-1127. doi: 10.1177/2050640620959155. Epub 2020 Sep 23.
4
Duration of symptoms and manometric parameters offer clues to diagnosis of pseudoachalasia.症状持续时间和测压参数为假性贲门失弛缓症的诊断提供线索。
Neurogastroenterol Motil. 2021 Jan;33(1):e13965. doi: 10.1111/nmo.13965. Epub 2020 Aug 10.
5
Gastroesophageal reflux after per-oral endoscopic myotomy is frequently asymptomatic, but leads to more severe esophagitis: A case-control study.经口内镜下肌切开术后胃食管反流通常无症状，但可导致更严重的食管炎：一项病例对照研究。
United European Gastroenterol J. 2021 Feb;9(1):63-71. doi: 10.1177/2050640620947645. Epub 2021 Feb 18.
6
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up.与辅助伊马替尼治疗 1 年相比，3 年治疗高危胃肠道间质瘤患者的生存结局：10 年随访后一项随机临床试验的分析。
JAMA Oncol. 2020 Aug 1;6(8):1241-1246. doi: 10.1001/jamaoncol.2020.2091.
7
Pseudoachalasia: a systematic review of the literature.假性贲门失弛缓症：文献系统综述。
Esophagus. 2020 Jul;17(3):216-222. doi: 10.1007/s10388-020-00720-1. Epub 2020 Jan 27.
8
KIT Mutation Incidence and Pattern of Melanoma in Central Europe.中欧黑色素瘤的 KIT 突变发生率和模式。
Pathol Oncol Res. 2020 Jan;26(1):17-22. doi: 10.1007/s12253-019-00788-w. Epub 2019 Dec 17.
9
Pseudoachalasia secondary to metastatic bladder cancer.继发于转移性膀胱癌的假性贲门失弛缓症。
BMJ Open Gastroenterol. 2019 Jul 11;6(1):e000284. doi: 10.1136/bmjgast-2019-000284. eCollection 2019.
10
Risk of esophageal cancer in achalasia cardia: A meta-analysis.贲门失弛缓症患者患食管癌的风险：一项荟萃分析。
JGH Open. 2019 Feb 8;3(3):196-200. doi: 10.1002/jgh3.12132. eCollection 2019 Jun.